Clinical trial
Erlotinib, Paclitaxel, and Carboplatin Combined With Radiation Therapy for Stage…
NCT00278148 · Nathan Pennell, MD, PhD, Other · Completed
Key facts
| NCT number | NCT00278148 |
|---|---|
| Title | Erlotinib, Paclitaxel, and Carboplatin Combined With Radiation Therapy for Stage III Non-Small Cell Lung Cancer |
| Official title | A Phase I/II Trial of Neoadjuvant Paclitaxel, Carboplatin and OSI-774 (Tarceva) With Concurrent Accelerated Hyperfractionation Radiation Followed by Maintenance Therapy With OSI-774 for Stage III Non-Small Cell Lung Cancer |
| Lead sponsor | Nathan Pennell, MD, PhD, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | carboplatin, Erlotinib, paclitaxel, conventional surgery, radiation therapy |
| Enrollment | 32 |
| Start date | Oct 1, 2005 |
| Primary completion | Feb 1, 2011 |
| Completion | Feb 1, 2011 |
| First posted | Jan 18, 2006 |
| Last update posted | Jul 20, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: